Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Onchocerca volvulus | Peroxidasin homolog | 0.0077 | 0 | 0.5 |
Onchocerca volvulus | 0.0077 | 0 | 0.5 | |
Loa Loa (eye worm) | macrophage migration inhibitory factor | 0.0171 | 1 | 1 |
Leishmania major | macrophage migration inhibitory factor-like protein | 0.0171 | 1 | 0.5 |
Onchocerca volvulus | Peroxidase homolog | 0.0077 | 0 | 0.5 |
Onchocerca volvulus | Peroxidase homolog | 0.0077 | 0 | 0.5 |
Schistosoma mansoni | peroxidasin | 0.0077 | 0 | 0.5 |
Entamoeba histolytica | macrophage migration inhibitory factor-like protein | 0.0171 | 1 | 0.5 |
Toxoplasma gondii | macrophage migration inhibitory factor, putative | 0.0171 | 1 | 0.5 |
Onchocerca volvulus | Chorion peroxidase homolog | 0.0077 | 0 | 0.5 |
Echinococcus granulosus | peroxidasin | 0.0077 | 0 | 0.5 |
Plasmodium falciparum | macrophage migration inhibitory factor | 0.0171 | 1 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0171 | 1 | 0.5 |
Plasmodium vivax | macrophage migration inhibitory factor, putative | 0.0171 | 1 | 0.5 |
Onchocerca volvulus | 0.0077 | 0 | 0.5 | |
Onchocerca volvulus | Peroxidasin homolog | 0.0077 | 0 | 0.5 |
Onchocerca volvulus | Dual oxidase homolog | 0.0077 | 0 | 0.5 |
Schistosoma mansoni | peroxidasin | 0.0077 | 0 | 0.5 |
Echinococcus multilocularis | peroxidasin | 0.0077 | 0 | 0.5 |
Trichomonas vaginalis | macrophage migration inhibitory factor, mif, putative | 0.0171 | 1 | 0.5 |
Leishmania major | macrophage migration inhibitory factor-like protein | 0.0171 | 1 | 0.5 |
Onchocerca volvulus | 0.0077 | 0 | 0.5 | |
Giardia lamblia | Macrophage migration inhibitory factor | 0.0171 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
K1/2 (binding) | = 35 uM | Activation of olfactory CNG A2A41b channel expressed in HEK293 cells assessed as effect on half maximal current | ChEMBL. | 17665892 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.